Akerman Senterfitt

About this office:

Akerman is ranked among the Top 100 law firms in the U.S. by The National Law Journal NLJ 250 (2008) in number of lawyers and is one of the largest firms in Florida. With more than 500 lawyers and government affairs professionals, we serve clients from major business centers in Florida, New York, Washington, D.C., California, Virginia, Colorado, and Texas.

Automotive, Bankruptcy and Reorganization, Class Actions, Climate Change, Construction, Consumer Finance Litigation, Corporate, Economic Development, E-Discovery, Employee Benefits and Executive Compensation, Energy, Utilities, and Telecommunications, Environment and Natural Resources, Fiduciary Litigation, Financial Institutions, Forest Resources, Franchising, Government Affairs and Public Policy, Government Contracts, Green and Sustainable Development, Healthcare, Hospitality, Immigration Planning and Compliance, Insurance Regulation and Litigation, Intellectual Property, Labor and Employment, Land Use and Entitlements, Life Sciences, Litigation, Mergers and Acquisitions, Private Client Services, Private Equity, Products Liability and Mass Torts, Public Finance, Public-Private Partnerships, Real Estate, Real Estate Litigation, Regulatory and Administrative, Retail Leasing and Development, Securities, Securitization and Structured Finance, Securities Litigation, Senior Living, Sports and Entertainment, Taxation, Transportation and Public Infrastructure, White Collar Crime and Government Investigations.

Pending Legislation Could Set "Clean Energy" Standard for Florida
Matthew J. Feil, April 30, 2009
In the last week, two committees in the Florida Senate have voted unanimously in favor of establishing a "clean energy" standard to replace the renewable energy standard that last year's Legislature directed the Public Service Commission to draft.

New Licensing Regulations for Physicians Who Purchase Prescription Drugs and For Entities Distributing Drugs
Martin R. Dix, November 18, 2009
The 2008 Florida Legislature passed HB 7049 as a major rewrite of the Florida Drugs, Devices and Cosmetics Act.

Return to the Akerman Senterfitt Firm Overview